JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors

Clinical trial NCT06226766 · TERMINATED

Trial details

NCT number: NCT06226766
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-01-18
Primary completion: 2025-07-31
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.